Sling-Fiber Preservation POEM vs. Conventional POEM for Reducing Post-POEM GERD
Key facts
- Who runs it
- University of California, Irvine
- Where
- Orange, United StatesSee the site
- Trial code
- Status
- Not yet recruiting
- People taking part
- 120 people, planned
- Started
- 1 Dec 2025
- Expected to end
- 1 Jan 2028
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Conventional POEM
- Sling Fiber-Preserving POEM
- Record updated
- 22 October 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (12)Hide the full registry criteria
Who can take part
- Age ≥ 18 years
- Diagnosis of achalasia (Type I-III) per Chicago Classification v3.0
- Deemed appropriate candidates for POEM
- Ability to provide informed consent
Who cannot take part
- Prior surgical myotomy (e.g., Heller myotomy)
- Spastic motility disorders other than achalasia type I-III (e.g. diffuse esophageal spasm, jackhammer esophagus, EGJ outflow obstruction)
- Coagulopathy or portal hypertension
- Sigmoid esophagus
- Contraindications to endoscopy or general anesthesia
- Pregnancy or actively breastfeeding
- Significant cardiopulmonary comorbidities that preclude safe endoscopic intervention
- Unwillingness or inability to complete follow-up assessments
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Gerd
Where in United States
- University of California - Irvine/UCI Medical CenterOrange, United StatesContact: Frances Dang, MDNot yet recruiting
About the trial
What the trial wants to find out
Peroral endoscopic myotomy (POEM) is an effective, minimally invasive treatment for achalasia, offering excellent rates of symptom relief. However, a significant drawback is the high incidence of gastroesophageal reflux disease (GERD) following the procedure. One proposed technical modification, the selective preservation of the sling fibers during gastric myotomy (SFP-POEM), may reduce this risk without compromising efficacy as compared to a conventional POEM procedure, which includes myotomy of the sling fibers. In this study, adults with achalasia will be randomly assigned to receive one of the two POEM technical approaches. Researchers will monitor whether preserving sling fibers reduces the rates of reflux esophagitis (classified as Los Angeles Grade B or higher) on follow-up endoscopy. Participants will be followed for up to 1 year after the procedure.
The 2 groups in the trial
- Conventional POEMExisting treatment, for comparison
Participants in this arm will undergo standard peroral endoscopic myotomy (POEM), including myotomy of circular and sling muscle fibers at the gastric side.
- Sling Fiber-Preservation POEMTreatment being tested
Participants in this arm will undergo posterior POEM with selective preservation of the gastric sling fibers. Myotomy is performed to the right of the second penetrating vessel to spare the sling fibers. The double scope technique will be employed to confirm that the tunnel ends on the lesser curve, which confirms sparing of the sling fibers.
Treatment: Sling Fiber-Preserving POEM
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Sling-Fiber Preservation POEM vs. Conventional POEM for Reducing Post-POEM GERD: A Randomized Control Trial
- Criteria questions
- Built from NCT07178821, who can take part
- Record updated
- 22 October 2025